Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118229) titled 'A prospective, multicenter, randomized, positive controlled clinical trial of rapamycin drug-coated intracranial stents for endovascular treatment of symptomatic intracranial atherosclerotic stenosis' on Feb. 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai East Hospital
Condition:
Symptomatic intracranial atherosclerotic stenosis
Intervention:
Test Group:Intracranial stents coated with rapamycin were used
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-12-30
Target Sample Size: Test Group:59;Control group:59;
Countries of Recruitment:
C...